|
| Press Releases |
|
 |
|
| Tuesday, December 6, 2022 |
|
|
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing |
| Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research (A*STAR); National University of Singapore (NUS); Nanyang Technological University, Singapore (NTU Singapore) and its innovation and enterprise company, NTUitive; and Singapore Institute of Technology (SIT) to boost Singapore's biologics manufacturing capabilities. more info >> |
|
| Thursday, June 2, 2022 |
|
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| Boehringer Ingelheim and the Agency for Science, Technology and Research (A*STAR) today announced a global licensing agreement under which Boehringer Ingelheim will obtain exclusive worldwide rights to research, develop and commercialize products based on a panel of innovative, tumor-specific antibodies from A*STAR. more info >> |
|
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| more info >> |
|
| Thursday, September 30, 2021 |
|
|
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes |
| The Agency for Science, Technology and Research (A*STAR) has developed an Automated Vaccine Inoculation Dispenser (AVID) system, which replaces the manual step of filling injection syringes with vaccine liquid. AVID is customised for the vaccination centres which are set up by the Ministry of Health and operated by private healthcare providers. more info >> |
|
| Friday, July 31, 2020 |
|
|
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials |
| Made-in-Singapore cancer drug, ETC-159, has achieved a new developmental milestone in achieving "First Patient First Visit[1]" in Phase 1B. The first dose of ETC-159 has been administered to patients in this new phase of clinical testing, which for the first time, will look at efficacy in addition to assessing the safety of ETC-159 in treating different types of cancers. more info >> |
|
| Friday, July 24, 2020 |
|
|
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2 |
| MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been operating for over 30 years focusing on various infectious disease testing development and manufacturing, today announced the successful development of a rapid antibody test kit for COVID-19, in collaboration with the Agency for Science, Technology and Research (A*STAR). more info >> |
|
| Tuesday, October 22, 2019 |
|
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
| Fujitsu Limited, the Singapore Management University (SMU) and the Agency for Science, Technology and Research (A*STAR)'s Institute of High Performance Computing today announced the launch of the Digital Platform Experimentation Project. more info >> |
|
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
| Fujitsu Limited, the Singapore Management University (SMU) and the Agency for Science, Technology and Research (A*STAR)'s Institute of High Performance Computing today announced the launch of the Digital Platform Experimentation Project. more info >> |
|
| Monday, October 21, 2019 |
|
|
富士通・シンガポール科学技術庁・Singapore Management University、「デジタルアニーラ」とディープラーニング技術を活用したプロジェクトを開始 |
| 富士通株式会社とシンガポール科学技術庁のハイパフォーマンスコンピューティング研究所（Institute of High Performance Computing）、およびSingapore Management Universityはこのたび、「FUJITSU Quantum-Inspired Computing Digital Annealer」とディープラーニング技術を活用したデジタルプラットフォーム実装プロジェクトを開始します。 more info >> |
|
| Friday, June 28, 2019 |
|
|
Singapore's Drug Development Efforts Given Additional Momentum with National Platforms |
| The nation's drug development efforts have been given additional momentum with the introduction of two new platforms, and a grant scheme for drug discovery and development. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Wallace MacDonald Holdings (WMH) Ignites a New Era of American Manufacturing with Revolutionary "Made in America" Technology Complex in Nevada
May 7, 2025 21:12 HKT/SGT
|
|
|
CALB (3931.HK) Announces Proposed Controlling Shareholding in Jiangsu Olive Sensors
May 7, 2025 21:08 HKT/SGT
|
|
|
CTF Life Title-Sponsored "Fencing Plus" Training Programme by Kai Tak Sports Initiative Officially Kicks Off
May 7, 2025 19:22 HKT/SGT
|
|
|
周大福人壽冠名贊助 - 飛越啟德「小劍神」培訓計劃正式啟動
May 7, 2025 19:05 HKT/SGT
|
|
|
周大福人寿冠名赞助 - 飞越启德「小剑神」培训计划正式启动
May 7, 2025 18:45 HKT/SGT
|
|
|
雲頂新耀宣佈耐賦康(R)獲得中國國家藥品監督管理局完全批准 全面拓展IgA腎病治療人群
May 7, 2025 18:08 HKT/SGT
|
|
|
Everest Medicines Announces NMPA Full Approval of NEFECON, Broadening Treatment Access for IgA Nephropathy Patients in China
May 7, 2025 18:06 HKT/SGT
|
|
|
云顶新耀宣布耐赋康(R)获得中国国家药品监督管理局完全批准 全面拓展IgA肾病治疗人群
May 7, 2025 18:06 HKT/SGT
|
|
|
Wallace MacDonald Holdings (WMH) Ignites a New Era of American Manufacturing with Revolutionary "Made in America" Technology Complex in Nevada
May 7, 2025 17:00: JST
|
|
|
全產業鏈貫通的抗血清頭部平台商：江西生物持續引領行業發展
May 7, 2025 15:37 HKT/SGT
|
|
|
全产业链贯通的抗血清头部平台商：江西生物持续引领行业发展
May 7, 2025 15:35 HKT/SGT
|
|
|
Honda、V型8気筒300馬力エンジン搭載の新型大型船外機「BF300」を発売
May 7, 2025 13:30: JST
|
|
|
富士通のソリューションを採用したソニー銀行様の新勘定系システムが稼働開始
May 7, 2025 13:30: JST
|
|
|
WIKA Reduces Debt by Rp1.47 Trillion, Improves Bond Rating in Q1-2025
May 7, 2025 10:00 HKT/SGT
|
|
|
中創新航擬控股蘇奧傳感 錨定新能源產業戰略併購
May 7, 2025 09:08 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
